While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution
See more from Diagnostic Imaging
New Study Points to Longer Duration of Axillary Lymphadenopathy After #COVID19 Vaccine https://t.co/hQEntGKvn7 @ACRRFS @ACRYPS @RadiologyACR @RSNA @ARRS_Radiology @futureradres @BreastImaging @UNCRadRes @WCMRadiology @WCMRadRes @curadresidents @UW_RadRes @USCRadResearch https://t.co/hQEntGKvn7 - view on twitter